These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25943745)

  • 1. Rosuvastatin Decreases Mean Platelet Volume in Patients With Diabetes Mellitus.
    Akyüz A; Akkoyun DÇ; Değirmenci H; Oran M
    Angiology; 2016 Feb; 67(2):116-20. PubMed ID: 25943745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin and Mean Platelet Volume in Diabetes.
    Papanas N; Maltezos E
    Angiology; 2016 Feb; 67(2):113-5. PubMed ID: 26085194
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment.
    Coban E; Afacan B
    Platelets; 2008 Mar; 19(2):111-4. PubMed ID: 17852772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin.
    Panes O; González C; Hidalgo P; Valderas JP; Acevedo M; Contreras S; Sánchez X; Pereira J; Rigotti A; Mezzano D
    Atherosclerosis; 2017 Feb; 257():164-171. PubMed ID: 28142075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of low-dose rosuvastatin in patients with type 2 diabetes and hypo high-density lipoprotein cholesterolaemia.
    Katabami T; Murakami M; Kobayashi S; Matsui T; Ujihara M; Takagi S; Higa M; Ichijo T; Ohta A; Tanaka Y
    J Int Med Res; 2014 Apr; 42(2):457-67. PubMed ID: 24595147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Thromb Res; 2017 Feb; 150():90-95. PubMed ID: 28068529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rosuvastatin on dyslipidemia and other parameters associated with metabolic syndrome in Saudi patients.
    Rafeeq MM; Habib HS; Murad H; Gari MA; Gazzaz ZJ
    Niger J Clin Pract; 2017 Apr; 20(4):445-453. PubMed ID: 28406125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
    Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of rosuvastatin on low-density lipoprotein subfractions in patients with impaired fasting glucose.
    Rizos CV; Kostapanos MS; Rizos EC; Tselepis AD; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):276-83. PubMed ID: 25237153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of rosuvastatin in achieving target HDL, LDL, triglycerides and total cholesterol levels in type 2 diabetes mellitus (T2DM) with newly diagnosed dyslipidaemia: an open label, nonrandomised, non-interventional and observational study in India.
    Shah SN; Arneja J
    J Assoc Physicians India; 2013 Oct; 61(10):721-6, 732. PubMed ID: 24772729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia.
    Werida R; Khairat I; Khedr NF
    Biomed Pharmacother; 2021 Mar; 135():111179. PubMed ID: 33401219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins decrease mean platelet volume irrespective of cholesterol lowering effect.
    Sivri N; Tekin G; Yalta K; Aksoy Y; Senen K; Yetkin E
    Kardiol Pol; 2013; 71(10):1042-7. PubMed ID: 24197585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
    Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.
    Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Atherosclerosis; 2015 Aug; 241(2):450-4. PubMed ID: 26074319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
    Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
    Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
    Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
    Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
    Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.